Dermapharm Holding SE

DMPHF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$121,195$158,724$149,918$160,319
Short-Term Investments$511$818$11,440$11,742
Receivables$105,005$95,406$100,149$76,083
Inventory$339,856$317,406$251,822$240,535
Other Curr. Assets$26,931$54,790$22,016$39,928
Total Curr. Assets$593,498$630,496$533,947$519,222
Property Plant & Equip (Net)$315,028$330,771$225,673$222,287
Goodwill$576,385$578,523$271,319$264,730
Intangibles$512,313$544,860$305,043$294,841
Long-Term Investments$82,285$75,345$65,414$94,147
Tax Assets$0$0$11,440$0
Other NC Assets$510$103,933$1$11,742
Total NC Assets$1,486,521$1,530,176$878,890$887,747
Other Assets$0$1-$1$0
Total Assets$2,080,019$2,160,673$1,412,836$1,406,969
Liabilities
Payables$94,785$86,641$56,100$52,101
Short-Term Debt$89,935$116,430$4,887$5,580
Tax Payable$67,419$81,818$110,749$60,194
Deferred Revenue$0$942$155,341$96,612
Other Curr. Liab.$74,776$108,658-$109,285-$58,874
Total Curr. Liab.$326,915$394,489$217,792$155,613
LT Debt$889,677$963,958$511,560$574,721
Deferred Rev, NC$11,337$0$9,204$9,456
Deferred Tax Liab, NC$111,703$0$50,518$36,056
Other NC Liab.$132,092$268,325$150,992$176,801
Total NC Liab.$1,144,809$1,232,283$662,552$751,522
Other Liabilities$0-$11,147$0$0
Cap. Leases$17,470$18,249$12,734$12,214
Total Liabilities$1,471,724$1,615,625$880,344$907,135
Equity
Pref Stock$0$0$0$0
Common Stock$53,840$53,840$53,840$53,840
Retained Earnings$433,191$367,223$355,357$337,954
AOCI$117,391$118,144$122,395$105,522
Other Equity$0$0$0$0
Total Equity$604,422$539,207$531,592$497,316
Supplemental Information
Minority Interest$3,873$5,841$900$2,518
Total Liab. & Tot. Equity$2,080,019$2,160,673$1,412,836$1,406,969
Net Debt$858,417$921,664$366,529$419,982
Dermapharm Holding SE (DMPHF) Financial Statements & Key Stats | AlphaPilot